Summit X LLC’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,589
Closed -$603K 34
2025
Q2
$603K Buy
3,589
+135
+4% +$20K 0.11% 129
2025
Q1
$476K Buy
3,454
+766
+28% +$97.6K 0.1% 131
2024
Q4
$318K Buy
2,688
+362
+16% +$42.3K 0.07% 157
2024
Q3
$229K Sell
2,326
-1,832
-44% -$192K 0.06% 186
2024
Q2
$400K Buy
+4,158
New +$424K 0.09% 145
2023
Q3
Sell
-3,685
Closed -$348K 197
2023
Q2
$348K Buy
3,685
+234
+7% +$19.8K 0.08% 195
2023
Q1
$266K Buy
+3,451
New +$260K 0.07% 225
2022
Q4
Sell
-2,818
Closed -$200K 245
2022
Q3
$200K Buy
+2,818
New +$179K 0.06% 235

Other funds holding CAH

Summit X LLC's CAH Position: Q3 2025 in Review

Summit X LLC sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 3,589 shares — an estimated $603K sold.

Summit X LLC first reported a position in CAH in Q3 2022 and held it in 8 quarters. The position peaked at $603K in Q2 2025. 1,225 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Summit X LLC reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
  • Summit X LLC sold 3,589 Cardinal Health shares in Q3 2025, an estimated $603K.
  • Summit X LLC first reported a position in Cardinal Health in Q3 2022 and held it in 8 quarters.
  • Summit X LLC's Cardinal Health position peaked at $603K in Q2 2025.
  • 1,225 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Summit X LLC's 13F filing for Q3 2025.